← All briefs
Oncology
Phase III
Featured
PD-1/PD-L1 Checkpoint Blockade in Non-Small Cell Lung Cancer
Perspectivum
624 ,
55-64 (2023)
·
10.1038/s41586-023-06894-5
·
NCT04604210
·
5:20
Visualisation of tumour-infiltrating lymphocyte reinvigoration following pembrolizumab administration, including TCR signalling cascade and apoptotic target engagement.
Customize
Reject All
Accept All
✖
Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.
None
Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.
None
Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.
None
Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.
None
Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
None